Mnemosyne Pharmaceuticals
Providence, US · Founded 2010 · Delaware corporation · 2 known investors
Founders & leadership
VK
Vanessa KingExecutive
KP
Kollol PalExecutive
FM
Frank MennitiNamed on SEC filing
Board
RH
Richard HoranBoard director
PB
Peter BarrettBoard director
DB
Daniel BehrBoard director
JB
James BristolBoard director
WK
William KosterBoard director
BB
Benjamin BronsteinBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$15.6M disclosed across 2 rounds · 2012
▶$12.3MraisedFeb 2015 · 6 investors · BiotechnologyRule 506(b)
▶$12.3MraisedFeb 2015 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- James BristolDirector
- Frank MennitiExecutive Officer
- Richard HoranDirector
- Peter BarrettDirector
- Vanessa KingExecutive Officer, Director
- William KosterDirector
- Offering amount
- $13M
- Amount sold
- $12.3M
- First sale
- Feb 2012
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06b
▶$3.2MraisedFeb 2012 · 4 investors · BiotechnologyRule 506(b)
▶$3.2MraisedFeb 2012 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard HoranDirector
- Daniel BehrDirector
- James BristolDirector
- Frank MennitiExecutive Officer
- Benjamin BronsteinDirector
- Kollol PalExecutive Officer, Director
- Offering amount
- $5.4M
- Amount sold
- $3.2M
- First sale
- Feb 2012
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Mnemosyne Pharmaceuticals's investors?
- Mnemosyne Pharmaceuticals's investors include Atlas Venture, Clal Biotechnology Industries.
- How much funding has Mnemosyne Pharmaceuticals raised?
- Mnemosyne Pharmaceuticals has disclosed $15.6M raised across 2 rounds.
- Where is Mnemosyne Pharmaceuticals headquartered?
- Mnemosyne Pharmaceuticals is headquartered in Providence, US.